Clinical Trial Update: Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Rituximab maintenance versus observation after first-line immunochemotherapy (FCR) in older patients with chronic lymphocytic leukemia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituxan (rituximab)

Snippet

Sponsor: University Hospital, Tours | Conditions: Leukemia | Phase 3 | Status: COMPLETED